Co-prevalence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian women with breast cancer

Hum Vaccin Immunother. 2016 Jul 2;12(7):1936-9. doi: 10.1080/21645515.2016.1139255. Epub 2016 Apr 15.

Abstract

ABSTRAT We recently performed 2 studies viewing the presence of Epstein-Barr virus (EBV) and high-risk human papillomaviruses (HPVs) types 16, 18, 31, 33 and 35 in human breast cancer in the Syrian population. Herein, we report that EBV and high-risk HPVs are co-present in breast cancer in Syrian women. Therefore, and based on our previous studies and present data, we reveal that 35 (32%) of 108 cancer samples are positive for both EBV and high-risk HPVs and their co-presence is associated with high grade invasive ductal carcinomas (IDCs) with at least one positive lymph nodes, in comparison with EBV and high-risk HPVs-positive samples, which are low to intermediate grade IDCs, respectively. Future studies are needed to confirm the co-presence and the cooperation effect of these onco-viruses in human breast carcinogenesis and metastasis.

Keywords: EBV; Syrian women; breast cancer; cancer phenotype; high-risk HPV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / complications*
  • Breast Neoplasms / pathology
  • Carcinoma, Ductal / complications*
  • Carcinoma, Ductal / pathology
  • Epstein-Barr Virus Infections / epidemiology*
  • Female
  • Herpesvirus 4, Human / isolation & purification*
  • Humans
  • Papillomaviridae / classification*
  • Papillomaviridae / isolation & purification*
  • Papillomavirus Infections / epidemiology*
  • Prevalence
  • Syria / epidemiology

Grants and funding